| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 65 |
| 1 | LETROZOLE | 63 |
| 2 | PACLITAXEL | 53 |
| 3 | LETROZOLE TABLETS | 52 |
| 4 | EVEROLIMUS | 45 |
| 5 | CARBOPLATIN | 40 |
| 6 | FULVESTRANT | 40 |
| 7 | DOCETAXEL | 39 |
| 8 | DOCETAXEL ANHYDROUS | 39 |
| 9 | ANASTROZOLE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SHARK CARTILAGE | 1 | 0.0119 |
| 1 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| 2 | VINORELBINE | 19 | 0.0027 |
| 3 | IBANDRONATE SODIUM | 6 | 0.0019 |
| 4 | TAMOXIFEN CITRATE | 11 | 0.0019 |
| 5 | GOSERELIN | 22 | 0.0016 |
| 6 | ANASTROZOLE TABLETS | 31 | 0.0014 |
| 7 | BRIGATINIB | 5 | 0.0014 |
| 8 | EXEMESTANE | 28 | 0.0013 |
| 9 | EVEROLIMUS TABLETS | 22 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 101 |
| 1 | Kinase Inhibitor [EPC] | 100 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 94 |
| 3 | Microtubule Inhibitor [EPC] | 77 |
| 4 | Platinum-based Drug [EPC] | 66 |
| 5 | Alkylating Drug [EPC] | 49 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 46 |
| 7 | Estrogen Receptor Antagonist [EPC] | 40 |
| 8 | Corticosteroid [EPC] | 37 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 40 | 0.0010 |
| 1 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 2 | Aromatase Inhibitor [EPC] | 101 | 0.0009 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Microtubule Inhibitor [EPC] | 77 | 0.0005 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 32 | 0.0004 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 94 | 0.0003 |
| 7 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 12 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |